Home » Topics » Regulatory » Patents

Patents
RSS

Gist-Brocades describes clavulanic acid diamine salts

Aug. 16, 1996

Ono claims PGE2 agonists and antagonists

Aug. 16, 1996

9-cis-retinoids as heart disease therapy described by American Cyanamid

Aug. 9, 1996

Ortho reveals fibrinogen antagonists

Aug. 9, 1996

Aldose reductase inhibitors disclosed by Nippon Zoki

Aug. 9, 1996

Astra reports gastrin secretion inhibitors

Aug. 9, 1996

Bicyclic fibrinogen antagonists described by SmithKline Beecham

Aug. 9, 1996

Piperazine fibrinogen antagonists from Thomae

Aug. 9, 1996

Thrombin inhibitors inhelabo's pipeline

Aug. 9, 1996

More nitric oxide synthase inhibitors from Japan Tobacco

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...